Format

Send to

Choose Destination
See comment in PubMed Commons below
Can J Cardiol. 2015 Jan;31(1):3-16. doi: 10.1016/j.cjca.2014.10.022. Epub 2014 Dec 19.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Author information

1
St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: moeg@smh.ca.
2
University of Alberta, Edmonton, Alberta, Canada.
3
Institut de Cardiologie de Montréal, Montreal, Québec, Canada.
4
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.
5
University of Calgary, Calgary, Alberta, Canada.
6
Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
7
St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
8
University of Waterloo, Waterloo, Ontario, Canada.
9
University Health Network, University of Toronto, Toronto, Ontario, Canada.
10
St Boniface General Hospital, Cardiac Sciences Program, Winnipeg, Manitoba, Canada.
11
Joseph Brant Memorial Hospital, Burlington, Ontario, Canada; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
12
Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
13
QE II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
14
Royal Jubilee Hospital, Victoria, British Columbia, Canada.
15
University of British Columbia, Vancouver, British Columbia, Canada.
16
University of Western Ontario, London, Ontario, Canada.
17
Penticton, British Columbia, Canada.
18
Université de Moncton, Moncton, New Brunswick, Canada.
19
Edmonton Cardiology Consultants, Edmonton, Alberta, Canada.
20
Cape Breton Regional Hospital, Sydney, Nova Scotia, Canada.
21
McGill University, Montreal, Québec, Canada.
22
Ottawa Heart Institute, Ottawa, Ontario, Canada.
23
Centre Hospitalier Régional de Lanaudière, Joliette, Québec and Université Laval, Québec, Canada.
24
Hôpital Laval, Sainte-Foy, Québec, Canada.
25
Health Sciences Centre, St John's, Newfoundland, Canada.

Erratum in

  • Can J Cardiol. 2016 Mar;32(3):394.

Abstract

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides discussion on the management recommendations on 3 focused areas: (1) anemia; (2) biomarkers, especially natriuretic peptides; and (3) clinical trials that might change practice in the management of patients with heart failure. First, all patients with heart failure and anemia should be investigated for reversible causes of anemia. Second, patients with chronic stable heart failure should undergo natriuretic peptide testing. Third, considerations should be given to treat selected patients with heart failure and preserved systolic function with a mineralocorticoid receptor antagonist and to treat patients with heart failure and reduced ejection fraction with an angiotensin receptor/neprilysin inhibitor, when the drug is approved. As with updates in previous years, the topics were chosen in response to stakeholder feedback. The 2014 Update includes recommendations, values and preferences, and practical tips to assist the clinicians and health care workers to best manage patients with heart failure.

PMID:
25532421
DOI:
10.1016/j.cjca.2014.10.022
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center